On September 25, 2015, the Environmental Protection Agency (EPA) published a proposed rule altering the regulatory regime governing the handling and disposal of hazardous waste pharmaceuticals generated at healthcare facilities and managed at pharmaceutical reverse distributors. The proposal is intended to simplify the regulatory burden of complying with the Resource Conservation and Recovery Act's (RCRA) cradle-to-grave management of hazardous wastes at healthcare facilities by providing an industry-specific approach to hazardous waste regulations that takes into account the realities of waste management within the industry. Currently, facilities that generate, ship, store, or dispose of hazardous waste pharmaceuticals must comply with all of the requirement of RCRA Subtitle C.